Synthesis of pyrazolo[4,3-d]pyrimidines with nanomolar CDK-inhibitory activity.
Preliminary kinase profiling of 5b reveals high selectivity for CDK2 and 5.
Compounds display cytostatic and pro-apoptotic effects.
Mechanism of action in cells corresponds to CDK inhibition.